<html><body><div style="font-family: arial,helvetica,sans-serif; font-size: 12pt; color: #000000"><div data-marker="__QUOTED_TEXT__"><div id="zimbraEditorContainer" style="font-family:'arial' , 'helvetica' , sans-serif;font-size:12pt;color:#000000" class="1"><br><div>---------------------------------------------------------------------------------------------------------------------------------</div><div>Gamma Multimodal Entrainment in Virtual Reality for Cognitive Enhancement in mental disorders</div><div><span style="color:#000000;font-family:'arial' , 'helvetica' , sans-serif;font-size:16px;font-style:normal;font-weight:400;letter-spacing:normal;text-indent:0px;text-transform:none;white-space:normal;word-spacing:0px;background-color:#ffffff;text-decoration:none;display:inline !important;float:none">---------------------------------------------------------------------------------------------------------------------------------</span><br></div><div>This PhD project develops a VirtualReality platform combining high-frequency neural </div><div>entrainment with cognitive-emotional training to treat mental disorders. Synchronous </div><div>observation of encephalographic data permits to identify neural biomarkers. </div><div>The approach targets both primary symptoms and underlying neurocognitive deficits </div><div>(attention, working memory) that impede traditional therapy. The project bridges immersive</div><div> technology, computational neuroscience, and clinical psychology to pioneer a newclass of </div><div>digital therapeutics for trauma.</div><br><div>This project inherently combines expertise spanning computational neuroscience, clinical</div><div>psychology, and immersive technology—domains that are essential but individually </div><div>insufficient to address mental disorder treatment innovation. Two partner teams bring </div><div>complementary and synergistic competencies: (i) the INRIA-team Nectarine (PI: Axel Hutt) </div><div>provides foundational expertise in non-invasive neuromodulation and computational neuroscience. </div><div>The team specializes in EEG signal processing, neural modeling, and biofeedback systems—</div><div>technical competencies essential for designing the multimodal entrainment protocols, integrating </div><div>real-time EEG recording with VR stimulation, extracting robust neurophysiological biomarkers, </div><div>and developing closed-loop neuromodulation frameworks. (ii) the IGG team (PI: Antonio </div><div>Capobianco) contributes human-centered Virtual Reality design, experimental protocol </div><div>robustness, and user experience optimization. IGG expertise ensures that the VR platform </div><div>deliversan engaging, safe, and immersive experience—critical for both participant tolerability </div><div>and thevalidity of behavioral measurements.</div><br><div>The project will be funded by ITI HealthTech (<a href="https://healthtech.unistra.fr/" style="font-family:'arial' , 'helvetica' , sans-serif;font-size:12pt;font-style:normal;font-weight:400;letter-spacing:normal;text-indent:0px;text-transform:none;white-space:normal;word-spacing:0px" target="_blank" rel="nofollow noopener noreferrer">https://healthtech.unistra.fr/<span class="Apple-converted-space"> </span></a>) in Strasbourg, France<a href="https://healthtech.unistra.fr/" style="font-size:12pt" target="_blank" rel="nofollow noopener noreferrer">.</a></div><br><div>Principal Investigators: </div><div>* Axel Hutt, Inria-team Nectarine (<a href="https://team.inria.fr/nectarine/" style="font-size:12pt" target="_blank" rel="nofollow noopener noreferrer">https://team.inria.fr/nectarine/</a><span style="font-size:12pt">)</span></div><div><span style="font-size:12pt">* Antonio Capobianco, iCube-team IGG (</span><a href="https://igg.icube.unistra.fr/index.php?title=Accueil" style="font-size:12pt" target="_blank" rel="nofollow noopener noreferrer">https://igg.icube.unistra.fr/index.php?title=Accueil</a><span style="font-size:12pt">)</span></div><div><span style="font-size:12pt"><br></span></div><div>Please submit your usual application documents or request for more information to </div><div>Axel Hutt (axel.hutt@inria.fr) or Antonio Capobianco (a.capobianco@unistra.fr). </div><div>Deadline for application is March 13, 2026</div><br><br><br><br><br><div>-- <br></div><div>Dr. rer. nat. Axel Hutt<br>Directeur de Recherche<br>Equipe NECTARINE - INRIA Nancy Center at University of Lorraine <br>Equipe MLMS - iCube Strasbourg<br>Bâtiment NextMed , 2, rue Marie Hamm<br>67000 Strasbourg, France</div></div><br></div></div></body></html>